Emalex Biosciences Inc.

This program provides early access to ecopipam for children, teens, and adults aged 6 to 50 with Tourette's disorder. The goal is to see if the drug is safe and tolerable over the long term, while also tracking quality of life. Participants receive the medication under their doct…